Format
Sort by
Items per page

Send to

Choose Destination

Best matches for XENOGRAFT:

Patient-derived xenograft models: an emerging platform for translational cancer research. Hidalgo M et al. Cancer Discov. (2014)

Bone graft substitute: allograft and xenograft. Shibuya N et al. Clin Podiatr Med Surg. (2015)

Xenograft bioprosthetic heart valves: Past, present and future. Manji RA et al. Int J Surg. (2015)

Search results

Items: 1 to 20 of 56070

1.

Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.

Liu R, Peng J, Wang H, Li L, Wen X, Tan Y, Zhang L, Wan H, Chen F, Nie X.

Cell Physiol Biochem. 2018 Sep 19;49(5):1717-1733. doi: 10.1159/000493615. [Epub ahead of print]

PMID:
30231242
2.

Synergistic Suppression of Melanoma Growth by a Combination of Natural dsRNA and Panaxadiolsaponins.

Zhao Y, Liu H, Xu L, Guo B, Kalvakolanu DV, Liu X, Hu J, Zhang D, Sun Y, Zhang L, Xu D, Zhao X.

J Interferon Cytokine Res. 2018 Sep;38(9):378-387. doi: 10.1089/jir.2018.0037.

PMID:
30230984
3.

MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.

Shen J, Zhou W, Bi N, Song YM, Zhang FQ, Zhan QM, Wang LH.

Cancer Biol Ther. 2018 Sep 19:1-8. doi: 10.1080/15384047.2018.1491505. [Epub ahead of print]

PMID:
30230945
4.

TGF-β/Smads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant Glioma.

Tao S, Liu M, Shen D, Zhang W, Wang T, Bai Y.

DNA Cell Biol. 2018 Sep 19. doi: 10.1089/dna.2018.4310. [Epub ahead of print]

PMID:
30230914
5.

Mapping electrical properties heterogeneity of tumor using boundary informed electrical properties tomography (BIEPT) at 7T.

Wang Y, Shao Q, Van de Moortele PF, Racila E, Liu J, Bischof J, He B.

Magn Reson Med. 2018 Sep 19. doi: 10.1002/mrm.27414. [Epub ahead of print]

PMID:
30230603
6.

Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1 deficient Group 2 Atypical Teratoid Rhabdoid Tumors to suppress tumor growth in vivo.

Alimova I, Pierce A, Danis E, Donson A, Birks DK, Griesinger A, Foreman NK, Santi M, Soucek L, Venkataraman S, Vibhakar R.

Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31873. [Epub ahead of print]

PMID:
30230537
7.

LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.

Ji D, Jiang C, Zhang L, Liang N, Jiang T, Yang B, Liang H.

J Cell Physiol. 2018 Sep 19. doi: 10.1002/jcp.27396. [Epub ahead of print]

PMID:
30230527
8.

Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.

Jiang JH, Pi J, Jin H, Cai JY.

J Cell Biochem. 2018 Sep 19. doi: 10.1002/jcb.27654. [Epub ahead of print]

PMID:
30229997
9.

Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation.

Zhang M, Cong Q, Zhang XY, Zhang MX, Lu YY, Xu CJ.

J Cell Physiol. 2018 Sep 19. doi: 10.1002/jcp.27369. [Epub ahead of print]

PMID:
30229902
10.

A gold nanoparticle system for enhancement of radiotherapy and simultaneous monitoring of reactive-oxygen-species formation.

Choi J, Jung K, Graves EE, Pratx G.

Nanotechnology. 2018 Sep 19. doi: 10.1088/1361-6528/aae272. [Epub ahead of print]

PMID:
30229748
11.

Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo.

Tan KT, Li S, Li YR, Cheng SL, Lin SH, Tung YT.

Appl Biochem Biotechnol. 2018 Sep 19. doi: 10.1007/s12010-018-2869-1. [Epub ahead of print]

PMID:
30229430
12.

Aptamer-Modified Magnetic Nanosensitizer for In Vivo MR Imaging of HER2-Expressing Cancer.

Heo D, Ku M, Kim JH, Yang J, Suh JS.

Nanoscale Res Lett. 2018 Sep 18;13(1):288. doi: 10.1186/s11671-018-2682-3.

PMID:
30229394
13.

Differential Proteome Analysis of Human Neuroblastoma Xenograft Primary Tumors and Matched Spontaneous Distant Metastases.

Hänel L, Gosau T, Maar H, Valentiner U, Schumacher U, Riecken K, Windhorst S, Hansen NO, Heikaus L, Wurlitzer M, Nolte I, Schlüter H, Lange T.

Sci Rep. 2018 Sep 18;8(1):13986. doi: 10.1038/s41598-018-32236-1.

PMID:
30228356
14.

Functional silencing of HSD17B2 in prostate cancer promotes disease progression.

Gao X, Dai C, Huang S, Tang J, Chen G, Li J, Zhu Z, Zhu X, Zhou S, Gao Y, Hou Z, Fang Z, Xu C, Wang J, Wu D, Sharifi N, Li Z.

Clin Cancer Res. 2018 Sep 18. pii: clincanres.2392.2018. doi: 10.1158/1078-0432.CCR-18-2392. [Epub ahead of print]

PMID:
30228209
15.

Tumor Growth Inhibition modelling based on receptor occupancy and biomarker activity of a new Bcl-2 inhibitor in mice.

Pierrillas PB, Henin E, Ogier J, Kraus-Berthier L, Chenel M, Bouzom F, Tod M.

J Pharmacol Exp Ther. 2018 Sep 18. pii: jpet.118.251694. doi: 10.1124/jpet.118.251694. [Epub ahead of print]

PMID:
30228112
16.

Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.

Yan TF, Wu MJ, Xiao B, Hu Q, Fan YH, Zhu XG.

Pathol Res Pract. 2018 Sep 12. pii: S0344-0338(18)30838-0. doi: 10.1016/j.prp.2018.09.001. [Epub ahead of print]

PMID:
30228024
17.

RBM17 controls apoptosis and proliferation to promote Glioma progression.

Lu J, Li Q, Cai L, Zhu Z, Guan J, Wang C, Xia J, Xia L, Wen M, Zheng W, Su Z, Wang C.

Biochem Biophys Res Commun. 2018 Sep 15. pii: S0006-291X(18)31975-2. doi: 10.1016/j.bbrc.2018.09.056. [Epub ahead of print]

PMID:
30227940
18.

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).

He X, Chen SY, Yang Z, Zhang J, Wang W, Liu MY, Niu Y, Wei XM, Li HM, Hu WN, Sun GG.

J Exp Clin Cancer Res. 2018 Sep 18;37(1):230. doi: 10.1186/s13046-018-0882-4.

PMID:
30227870
19.

Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment.

Zhang R, Ma M, Lin XH, Liu HH, Chen J, Chen J, Gao DM, Cui JF, Ren ZG, Chen RX.

BMC Cancer. 2018 Sep 18;18(1):901. doi: 10.1186/s12885-018-4820-9.

PMID:
30227844
20.

The dual sex hormone specificity for human reductive 17β-hydroxysteroid dehydrogenase type 7: synergistic function in estrogen and androgen control.

Thériault JF, Lin SX.

J Steroid Biochem Mol Biol. 2018 Sep 15. pii: S0960-0760(18)30165-1. doi: 10.1016/j.jsbmb.2018.09.012. [Epub ahead of print]

PMID:
30227243

Supplemental Content

Loading ...
Support Center